References
- Momtazmanesh S, Moghaddam SS, Ghamari S-H, et al. Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the global burden of disease study 2019. eClinicalMedicine. 2023;59:1.
- British Lung Foundation. Asthma Statistics; 2023.
- All Party Parliamentary Group on Respiratory Health. Report on inquiry into respiratory deaths. https://www.blf.org.uk/sites/default/files/APPG-Respiratory-deaths-2014-online.pdf;2014.Accessed March 27, 2024.
- Halpin DM, Miravitlles M. Chronic obstructive pulmonary disease: the disease and its burden to society. Proc Am Thorac Soc. 2006;3(7):619–623. doi:10.1513/pats.200603-093SS
- Devereux G. Definition, epidemiology, and risk factors. BMJ. 2006;332(7550):1142–1144. doi:10.1136/bmj.332.7550.1142
- NHS Digital. Quality and Outcomes Framework; 2020-21. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/quality-and-outcomes-framework-achievement-prevalence-and-exceptions-data/2020-21;2021.Accessed March 27, 2024.
- Chief Medical Officer. It takes your breath away. The impact of Chronic Obstructive Pulmonary Disease Annual Report; 2004.
- Kaul B, Cottin V, Collard HR, Valenzuela C. Variability in global prevalence of interstitial lung disease. Front Med. 2021;8:751181. doi:10.3389/fmed.2021.751181
- Cottin V, Teague R, Nicholson L, Langham S, Baldwin M. The Burden of Progressive-Fibrosing Interstitial Lung Diseases. Front Med. 2022;9:799912. doi:10.3389/fmed.2022.799912
- Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Europ resp J. 2015;46(3):795–806. doi:10.1183/09031936.00185114
- Gayle A, Lenoir A, Minelli C, Quint J. Are we missing lifetime COPD diagnosis among people with COPD recorded death? A population-based retrospective cohort study. BJGP Open. 2022;6(4):BJGPO.2022.0060. doi:10.3399/BJGPO.2022.0060
- Whittaker H, Rothnie KJ, Quint JK. Investigating the impact of using definitions of exacerbations of COPD of varying validity on study findings in routinely collected electronic healthcare records. In: American Thoracic Society. Washington DC; 2023.
- Stone PW, Osen M, Ellis A, Coaker R, Quint JK. Prevalence of chronic obstructive pulmonary disease in England from 2000 to 2019. Int J Chron Obstruct Pulmon Dis. 2023;18:1565–1574. doi:10.2147/COPD.S411739
- Clinical Practice Research Datalink. CPRD Aurum February 2022. Datalink CPR, editor;2022.
- Ford DV, Jones KH, Verplancke JP, et al. The SAIL Databank: building a national architecture for e-health research and evaluation. BMC Health Serv Res. 2009;9(1):157. doi:10.1186/1472-6963-9-157
- Jones KH, Ford DV, Thompson S, Lyons RA. A profile of the SAIL databank on the UK secure research platform. Interna J Pop Data Sci. 2019;4(2):1134. doi:10.23889/ijpds.v4i2.1134
- Lyons RA, Jones KH, John G, et al. The SAIL databank: linking multiple health and social care datasets. BMC Med Inf Decis Making. 2009;9(1):3. doi:10.1186/1472-6947-9-3
- DataLoch. About the Data https://dataloch.org/data/about-The-data2023.Accessed March 27, 2024.
- NHS Digital. Read Codes https://digital.nhs.uk/services/terminology-and-classifications/read-codes2022.Accessed March 27, 2024.
- Quint JK, Müllerova H, DiSantostefano RL, et al. Validation of chronic obstructive pulmonary disease recording in the clinical practice research datalink (CPRD-GOLD). BMJ Open. 2014;4(7):e005540. doi:10.1136/bmjopen-2014-005540
- Nissen F, Morales DR, Mullerova H, Smeeth L, Douglas IJ, Quint JK. Validation of asthma recording in the clinical practice research datalink (CPRD). BMJ Open. 2017;7(8):e017474. doi:10.1136/bmjopen-2017-017474
- Morgan A, Gupta RS, George PM, Quint JK. Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England. BMC Pulm Med. 2023;23(1):256. doi:10.1186/s12890-023-02550-0
- Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827–836. doi:10.1093/ije/dyv098
- Bhaskaran K, Forbes HJ, Douglas I, Leon DA, Smeeth L. Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD). BMJ Open. 2013;3(9):e003389. doi:10.1136/bmjopen-2013-003389
- Mathur R, Bhaskaran K, Chaturvedi N, et al. Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health. 2014;36(4):684–692. doi:10.1093/pubmed/fdt116
- Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the general practice research database. Pharmacoepidemiol Drug Saf. 2005;14(7):443–451. doi:10.1002/pds.1115
- GSS Harmonisation Team. Ethnicity harmonised standard. https://analysisfunction.civilservice.gov.uk/policy-store/ethnicity-harmonised-standard/;2011.Accessed March 27, 2024.
- Whittaker HR, Kiddle SJ, Quint JK. Challenges and pitfalls of using repeat spirometry recordings in routine primary care data to measure FEV(1) decline in a COPD Population. Prag Obser Res. 2021;12:119–130. doi:10.2147/POR.S319965
- Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(Suppl 16):5–40. doi:10.1183/09041950.005s1693
- Strongman H, Kausar I, Maher TM. Incidence, prevalence, and survival of patients with idiopathic pulmonary fibrosis in the UK. Adv Therapy. 2018;35(5):724–736. doi:10.1007/s12325-018-0693-1
- European medicines agency: science medicines health. Trelegy Ellipta https://www.ema.europa.eu/en/medicines/human/EPAR/trelegy-ellipta2023.Accessed March 27, 2024.
- European medicines agency: science medicines health. Trimbow https://www.ema.europa.eu/en/medicines/human/EPAR/trimbow2023.Accessed March 27, 2024.
- Kawano-Dourado L, Glassberg MK, Assayag D, Borie R, Johannson KA. Sex and gender in interstitial lung diseases. Eur Respir Rev. 2021;30(162):210105. doi:10.1183/16000617.0105-2021
- Salciccioli JD, Marshall DC, Goodall R, et al. Interstitial lung disease incidence and mortality in the UK and the European Union: an observational study, 2001–2017. ERJ Open Res. 2022;8(3):00058–2022. doi:10.1183/23120541.00058-2022
- Gershon AS, Dolmage TE, Stephenson A, Jackson B. Chronic obstructive pulmonary disease and socioeconomic status: a systematic review. Copd. 2012;9(3):216–226. doi:10.3109/15412555.2011.648030
- Sahni S, Talwar A, Khanijo S, Talwar A. Socioeconomic status and its relationship to chronic respiratory disease. Adv Respira Med. 2017;85(2):97–108. doi:10.5603/ARM.2017.0016
- Schyllert C, Lindberg A, Hedman L, et al. Low socioeconomic status relates to asthma and wheeze, especially in women. ERJ Open Res. 2020;6(3):00258–2019. doi:10.1183/23120541.00258-2019
- Hancox RJ, Milne BJ, Taylor DR, et al. Relationship between socioeconomic status and asthma: a longitudinal cohort study. Thorax. 2004;59(5):376–380. doi:10.1136/thx.2003.010363